Visual field defect after facial rejuvenation with botulinum toxin type A and polyacrylamide hydrogel injection.
Department of Ophthalmology; Chang Gung Memorial Hospital; Chang Gung University; College of Medicine; Taoyuan, Taiwan.
Yi-Hsing
YH
Chen
Yueh-Ju
YJ
Tsai
An-Ning
AN
Chao
Yih-Shiou
YS
Huang
Ling Yuh
LY
Kao
D000180:Acrylic Resins / Q000008:administration & dosage / Q000009:adverse effects*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects*; D003357:Cosmetic Techniques / Q000009:adverse effects*; D005145:Face; D005260:Female; D005782:Gels; D006801:Humans; D020100:Hydrogels / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D015840:Oculomotor Nerve Diseases / Q000209:etiology*; D018917:Optic Neuropathy, Ischemic / Q000209:etiology*; D054517:Orbital Cellulitis / Q000209:etiology*; D012060:Rejuvenation; D014792:Visual Acuity; D014794:Visual Fields
D000180:Acrylic Resins; C486838:Aquamid; D005782:Gels; D020100:Hydrogels; D019274:Botulinum Toxins, Type A